Ally P. Chief
- Accomplished Systems Biology Leader with over 15 years of professional industry experience in Drug and Target Discovery, as well as Translational and Precision Medicine.
- Strategic visionary with a track record of conception and development of integrative analysis approaches and delivery of actionable results.
- Multifaceted scientist capable of leading cross-functional, matrixed, and cross-continental teams internally and with external collaborations, partnerships, and KOLs.
- Strong scientific program and project manager with proven ability to attract, retain, mentor and grow talent.
Her personal and professional motivation has always been to make a difference in healthcare by aiding in delivery or development of more scientifically powered medicine.
Specialized kills and areas of key strengths include:
-Systems Therapeutics
-Precision Oncology
-Tumor Cell Biology
-Drug Resistance Mechanisms in Cancer
-Actionable Pathway Analysis
-Multi-Omic Network Reconstruction
-Target Identification and Prioritization
-Clinical Trial Matching
-Clinical Trial Data Analysis
-Drug and Target Mechanism of Action (MoA)
-Drug Repositioning
-Companion Diagnostics
-Cancer Diagnostics
-Clinical Reporting
-Systems Chemical Biology
-Disease Etiology and Mechanistic Hypothesis
-Patient Stratification
-Safety and Tox Assessment
-Biomarker Discovery
-Integrated and Functional Genomics
-Genotype-Phenotype Integration & Interpretation
-Multi-Hit Genetic and Environmental Causal Disease Hypotheses
-Multi-Scale Biology (genomics, proteomics, metabolomics, transcriptomics, epigenetics, etc., ...)
-Cell Signaling / Signal Transduction / Pathway Cross-Talk / Converging Pathways/ Molecular Network Modeling/ Mechanistic Models / Pathway Activity and Target Activity Inference
-Literature Curation & Content Management
-Multidisciplinary Team Management
-Product Development
-Competitive Intelligence
-Process Automation
-Thought Leadership
-Scientific and Technical Writing
-Public Speaking
- Strategic visionary with a track record of conception and development of integrative analysis approaches and delivery of actionable results.
- Multifaceted scientist capable of leading cross-functional, matrixed, and cross-continental teams internally and with external collaborations, partnerships, and KOLs.
- Strong scientific program and project manager with proven ability to attract, retain, mentor and grow talent.
Her personal and professional motivation has always been to make a difference in healthcare by aiding in delivery or development of more scientifically powered medicine.
Specialized kills and areas of key strengths include:
-Systems Therapeutics
-Precision Oncology
-Tumor Cell Biology
-Drug Resistance Mechanisms in Cancer
-Actionable Pathway Analysis
-Multi-Omic Network Reconstruction
-Target Identification and Prioritization
-Clinical Trial Matching
-Clinical Trial Data Analysis
-Drug and Target Mechanism of Action (MoA)
-Drug Repositioning
-Companion Diagnostics
-Cancer Diagnostics
-Clinical Reporting
-Systems Chemical Biology
-Disease Etiology and Mechanistic Hypothesis
-Patient Stratification
-Safety and Tox Assessment
-Biomarker Discovery
-Integrated and Functional Genomics
-Genotype-Phenotype Integration & Interpretation
-Multi-Hit Genetic and Environmental Causal Disease Hypotheses
-Multi-Scale Biology (genomics, proteomics, metabolomics, transcriptomics, epigenetics, etc., ...)
-Cell Signaling / Signal Transduction / Pathway Cross-Talk / Converging Pathways/ Molecular Network Modeling/ Mechanistic Models / Pathway Activity and Target Activity Inference
-Literature Curation & Content Management
-Multidisciplinary Team Management
-Product Development
-Competitive Intelligence
-Process Automation
-Thought Leadership
-Scientific and Technical Writing
-Public Speaking